Our team identified BAP31 as cancer/testis antigen for the first time, and found that its expression was correlated with the stage and grade of cervical cancer, and its abnormally high expression promoted the progression of cervical cancer 11. This evidence concerns the gene BCAP31 and cervical cancer.